Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
2.
Can J Gastroenterol ; 23(9): 625-31, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19816627

ABSTRACT

The present article describes three difficult cases of recurrent bleeding from obscure causes, followed by a review of the pitfalls and pharmacological management of obscure gastrointestinal bleeding. All three patients underwent multiple investigations. An intervening complicating diagnosis or antiplatelet drugs may have compounded longterm bleeding in two of the cases. A bleeding angiodysplasia was confirmed in one case but was aggravated by the need for anticoagulation. After multiple transfusions and several attempts at endoscopic management in some cases, long-acting octreotide was associated with decreased transfusion requirements and increased hemoglobin levels in all three cases, although other factors may have contributed in some. In the third case, however, the addition of low-dose thalidomide stopped bleeding for a period of at least 23 months.


Subject(s)
Gastrointestinal Hemorrhage/diagnosis , Gastrointestinal Hemorrhage/drug therapy , Aged , Aged, 80 and over , Angiodysplasia/complications , Angiodysplasia/diagnostic imaging , Angiodysplasia/surgery , Angiogenesis Inhibitors/therapeutic use , Angiography , Animals , Antifibrinolytic Agents/therapeutic use , Blood Vessel Prosthesis , Blood Vessel Prosthesis Implantation/instrumentation , Capsule Endoscopy , Colonoscopy , Fatal Outcome , Female , Gastrointestinal Agents/therapeutic use , Gastrointestinal Hemorrhage/etiology , Gastrointestinal Hemorrhage/surgery , Gastroscopy , Humans , Mesenteric Artery, Superior/diagnostic imaging , Mesenteric Artery, Superior/surgery , Octreotide/therapeutic use , Prosthesis Design , Recurrence , Thalidomide/therapeutic use , Tranexamic Acid/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...